Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges

毒性 少年 医学 毒理 内科学 生物 遗传学
作者
Christopher Bowman,Gary W. Chmielewski,Elise Lewis,Sharon L. Ripp,Christopher M. Sawaryn,David M. Cross
出处
期刊:Teratology [Wiley]
卷期号:: n/a-n/a 被引量:9
标识
DOI:10.1002/bdrb.20301
摘要

BACKGROUND: Anidulafungin, an echinocandin antifungal marketed for adult use, is being considered for use in pediatric populations, including neonates. The evolution of the nonclinical pediatric safety strategy for anidulafungin serves as an example of case-by-case negotiation through the European Medicines Agency pediatric investigation plan process, resulting in an acceptable juvenile rat toxicity study. METHODS: Study design challenges included animal selection, route, dose, age, and duration of dosing in relation to brain maturity, and appropriate study endpoints. The definitive study consisted of subcutaneous dosing at 0, 3, 10, and 30 mg/kg/day from postnatal day 4 to 62 (preterm infant to adulthood) with a 5-week recovery period. Study endpoints evaluated the potential for increased juvenile sensitivity to liver toxicity (seen in adults) and for novel toxicities in the central nervous system. RESULTS: Anidulafungin-related effects included slightly reduced body weight, increased liver weight, and a mild decrease in red blood cell mass with increased reticulocyte count. There was no liver pathology and in the posttreatment phase there were no effects on neurological function. Following recovery, effects on body weight, hematology, and liver weight were reversing or reversed. CONCLUSIONS: Therefore, the juvenile rat no-adverse-effect-level was 30 mg/kg/day. Exposures at this dose are similar to those achieved at the adult rat no-adverse-effect-level, suggesting that the juvenile rat is no more sensitive to anidulafungin than the adult rat. In conclusion, dialog and negotiation between the sponsor and the European Medicines Agency allowed for successful execution of a nonclinical safety strategy that enabled further clinical investigation of anidulafungin in pediatric populations. Birth Defects Res (Part B) 92:333–344, 2011. © 2011 Wiley-Liss, Inc.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
周一发布了新的文献求助10
刚刚
周一发布了新的文献求助20
刚刚
周一发布了新的文献求助10
刚刚
Hello的应助被HuiYmao采纳,获得10
刚刚
周一发布了新的文献求助10
刚刚
今后的应助被一枝清荷采纳,获得10
1秒前
3秒前
周一发布了新的文献求助30
3秒前
4秒前
4秒前
4秒前
辛勤的盼夏完成签到,获得积分10
4秒前
复杂的扬完成签到,获得积分10
4秒前
搜集达人的应助被tulip采纳,获得10
5秒前
完美世界的应助被also采纳,获得10
5秒前
25778完成签到 ,获得积分10
6秒前
科研通AI6.4的应助被Ki采纳,获得10
7秒前
7秒前
8秒前
KuangNK发布了新的文献求助10
8秒前
美满的安柏完成签到,获得积分10
9秒前
yingzi完成签到,获得积分10
10秒前
NexusExplorer的应助被Cold采纳,获得10
11秒前
ladyyoung完成签到,获得积分10
11秒前
12秒前
耶耶发布了新的文献求助10
12秒前
明亮涫发布了新的文献求助20
13秒前
四时令发布了新的文献求助30
13秒前
14秒前
15秒前
ayida完成签到,获得积分10
15秒前
粗犷的书蝶完成签到,获得积分20
15秒前
yhn发布了新的文献求助10
15秒前
15秒前
15秒前
漠尘完成签到,获得积分10
16秒前
16秒前
16秒前
17秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193599
求助须知:如何正确求助?哪些是违规求助? 9579723
关于积分的说明 21867157
捐赠科研通 7793198
什么是DOI,文献DOI怎么找? 3437314
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484193